PIAS3 (protein inhibitor of activated STAT, 3)
2010-04-01 Gilles Spoden  , Werner Zwerschke   AffiliationDNA/RNA
Note
The gene codes for a protein of the PIAS family (protein inhibitor of activated STAT (signal transducer and activator of transcription)). PIAS3 regulates the activity of several transcription factors by direct protein-protein interaction. Further, PIAS3 is a SUMO (small ubiquitin-like modifier)-E3 ligase, catalyzing the covalent, post-translational modification of specific target proteins with SUMO. Different splice variants of PIAS3 have been identified but the full-length sequence of some of these variants has not been described.

Figure 1. PIAS3 gene 10559 bp. Exons 1 to 14 (UTR in white, coding sequence in red) Exon 1: 1-115 (5UTR: 1-91); Exon 2: 2075-2492; Exon 3: 2650-2734; Exon 4: 2963-3013; Exon 5: 3255-3345; Exon 6: 4201-4335; Exon 7: 4518-4623; Exon 8: 5195-5268; Exon 9: 5417-5577; Exon 10: 7928-8061; Exon 11: 8142-8310; Exon 12: 8495-8628; Exon 13: 8812-8849; Exon 14: 9369-10559 (3UTR: 9636-10559).
Description
The human PIAS3 gene is 10559 bp long and consists of 14 exons and 13 introns.
Transcription
Transcript length 2902 bp (CDS 1887 bp ; residues 628 aa).
Pseudogene
No pseudogene reported.
Proteins

Figure 2. The schematic domain structure of human PIAS3 protein is shown. SAP domain: nuclear localization and binding to DNA, transcription factors, coregulators. PINIT: nuclear retention, transcriptional repression. SP-RING: protein-protein interactions, interacts with the SUMO conjugase Ubc9, sumoylation. SIM: binding to SUMO. S/T: variable region, binding to coactivators.
Description
The human PIAS3 protein is a E3 SUMO-protein ligase consisting of 628 amino acids. It contains 5 conserved regions, the SAP, PINIT, SP-RING, SIM and S/T domains (figure 2).
Expression
PIAS3 is ubiquitously expressed.
Localisation
Nuclear as well as cytoplasmic localization.
Function
PIAS3 belongs to the mammalian protein inhibitor of activated STAT (PIAS) protein family, originally identified as cytokine-induced inhibitors of the STAT family of transcription factors. This protein class, referred to as SUMO-E3 ligases, increases the efficiency of SUMO conjugation. SUMO, a small ubiquitin-like modifier protein, is conjugated to a large number of cellular target proteins. Similar to enzymatic ubiquitination, the conjugation of specific SUMO proteins (SUMO-1-SUMO-3) to target proteins requires an E1-activating enzyme (Aos1/Uba2) as well as an E2-type SUMO-1-conjugating enzyme (Ubc9). Similar to many ubiquitin E3 ligases, these proteins contain a putative RING finger-like structure (SP-RING, figure 2), which is essential for their SUMO-E3 ligase activities toward various target proteins. Sumoylation is a dynamic process with highly diverse outcomes, ranging from changes in subcellular localization, signal transduction, transcriptional regulation to altered activity and stability of the modified protein. PIAS3 do, however, not only operate as SUMO-E3, since its coregulator effects are often independent of its RING-finger like domain but dependent on its capability to interact with sumoylated proteins via its conserved SIM (SUMO-interacting motif) or SAP (scaffold attachment factor-A/B/acinus/PIAS) domain (figure 2). Beside the N-terminal SAP, the SIM and the RING-type zinc-binding domain, a PINIT motif, and a serine/ threonine-rich C-terminal region (S/T) is conserved in PIAS3 (figure 2).
PIAS3 is involved in cytoplasmic regulation, such as functional interaction of PIAS3 with metabotropic glutamate receptor-8, voltage-gated potassium channel Kv1.5 and pyruvate kinase subtype M2, but the majority of so far reported interactions of the PIAS3 protein occurred with transcription factors or other proteins linked to nuclear regulation. PIAS3 can act in both transcriptional repression and activation. PIAS3 has been shown to repress STAT3 and Stat5 dependent transcriptional activation by blocking the DNA-binding of the factor without influencing its sumoylation. It interacts with and promotes sumoylation of the photoreceptor-specific transcription factor Nr2e3 when bound to specific promoters, which converts the factor to a transcriptional repressor. Moreover, PIAS3 was described as a repressor of microphthalmia transcription factor (MITF) and it was shown that PIAS3 blocks NF-kB mediated transcriptional activation by interacting with the p65/RelA subunit. Repression of IRF1-mediated transcription by PIAS3 has also been shown. PIAS3 has been shown to activate transcription mediated by Smad proteins through forming a complex with Smads and coactivator p300/CBP; moreover, PIAS proteins enhance steroid receptor-dependent transcription through an SP-RING-mediated interaction and sumoylation of the coactivator protein GRIP1/SCR2. Finally, PIAS3 was shown to modulate the ability of TIF2 to mediate ligand-enhanced transcription activation positively or negatively, for different steroid receptors.
PIAS3 is involved in cytoplasmic regulation, such as functional interaction of PIAS3 with metabotropic glutamate receptor-8, voltage-gated potassium channel Kv1.5 and pyruvate kinase subtype M2, but the majority of so far reported interactions of the PIAS3 protein occurred with transcription factors or other proteins linked to nuclear regulation. PIAS3 can act in both transcriptional repression and activation. PIAS3 has been shown to repress STAT3 and Stat5 dependent transcriptional activation by blocking the DNA-binding of the factor without influencing its sumoylation. It interacts with and promotes sumoylation of the photoreceptor-specific transcription factor Nr2e3 when bound to specific promoters, which converts the factor to a transcriptional repressor. Moreover, PIAS3 was described as a repressor of microphthalmia transcription factor (MITF) and it was shown that PIAS3 blocks NF-kB mediated transcriptional activation by interacting with the p65/RelA subunit. Repression of IRF1-mediated transcription by PIAS3 has also been shown. PIAS3 has been shown to activate transcription mediated by Smad proteins through forming a complex with Smads and coactivator p300/CBP; moreover, PIAS proteins enhance steroid receptor-dependent transcription through an SP-RING-mediated interaction and sumoylation of the coactivator protein GRIP1/SCR2. Finally, PIAS3 was shown to modulate the ability of TIF2 to mediate ligand-enhanced transcription activation positively or negatively, for different steroid receptors.
Implicated in
Entity name
Prostate Cancer
Oncogenesis
PIAS3 is expressed in normal prostate and in prostate cancer cells and has been shown to modulate the transcriptional activity of androgen receptor in prostate cancer cells. Moreover, PIAS3 (KChAP) induces increased K+ efflux and apoptosis in prostate cancer lines.
Entity name
Glioblastoma multiforme (GBM)
Oncogenesis
The activation of STATs and loss of their natural inhibitors SOCS and PIAS is common in various human cancers. STAT3, a cytoplasmic transcription factor that becomes activated in response to a variety of cytokines and growth factors is aberrantly activated in GBM tumors. STAT3 activation correlates with strongly reduced PIAS3 protein expression in GBM tissues. Inhibition of PIAS3 resulted in enhanced glioblastoma cellular proliferation, and, conversely, PIAS3 overexpression inhibits STAT3 transcriptional activity, expression of STAT3-regulated genes, and cell proliferation. This suggests that the loss of PIAS3 in GBM contributes to enhanced STAT3 transcriptional activity and subsequent cell proliferation.
Entity name
Melanoma
Oncogenesis
PIAS3 functions as a key molecule in suppressing the transcriptional activity of both MITF and STAT3, two transcription factors that play a major role in the development, proliferation and survival of mast cells and melanocytes. In addition to its role in normal cell signaling, constitutively activated STAT3 signaling directly contributes to oncogenesis in many human cancers. STAT3 cooperates with MITF in the induction of cellular transformation. Evidence was provided suggesting that PIAS3 halt proliferation and induce apoptotic cell death in mast cells and in melanoma cells by inhibiting the transcriptional activity of the two oncogenic factors MITF and STAT3. Therefore PIAS3 may play a role in tumor suppression by inhibiting oncogenic processes induced by STAT3 and MITF.
Entity name
Non-small cell lung cancer (NSCLC)
Disease
The Epidermal Growth Factor Receptor (EGFR)-STAT3 axis plays an important role in oncogenic signaling of non-small cell lung cancer (NSCLC). The negative regulator of STAT3-mediated transcriptional activation, PIAS3, was shown to modulate oncogenic EGFR-STAT3 signaling in lung cancer. Overexpression of PIAS3 decreases STAT3 transcriptional activity and proliferation of NSCLC cells and when used in conjunction with EGFR inhibitors, further increased the anti-proliferative effects. This suggests that PIAS3 acts as an inhibitor of EGFR-STAT3 induced oncogenic action.
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|
| 10851046 | 2000 | STATs in oncogenesis. | Bowman T et al |
| 18676737 | 2008 | Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression. | Brantley EC et al |
| 10851045 | 2000 | The role of STATs in transcriptional control and their impact on cellular function. | Bromberg J et al |
| 9388184 | 1997 | Specific inhibition of Stat3 signal transduction by PIAS3. | Chung CD et al |
| 14596924 | 2003 | The 'PINIT' motif, of a newly identified conserved domain of the PIAS protein family, is essential for nuclear retention of PIAS3L. | Duval D et al |
| 18000527 | 2007 | Concepts in sumoylation: a decade on. | Geiss-Friedlander R et al |
| 11439351 | 2001 | Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells. | Gross M et al |
| 11390354 | 2001 | The Drosophila Su(var)2-10 locus regulates chromosome structure and function and encodes a member of the PIAS protein family. | Hari KL et al |
| 11595179 | 2001 | SP-RING for SUMO: new functions bloom for a ubiquitin-like protein. | Hochstrasser M et al |
| 15140884 | 2004 | PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit. | Jang HD et al |
| 12208521 | 2002 | PIAS3 (protein inhibitor of activated STAT-3) modulates the transcriptional activation mediated by the nuclear receptor coactivator TIF2. | Jiménez-Lara AM et al |
| 15189146 | 2004 | Protein modification by SUMO. | Johnson ES et al |
| 14737107 | 2004 | STAT3 and MITF cooperatively induce cellular transformation through upregulation of c-fos expression. | Joo A et al |
| 11071847 | 2000 | Protein inhibitor of activated STAT3 regulates androgen receptor signaling in prostate carcinoma cells. | Junicho A et al |
| 17236129 | 2007 | Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopenia-absent radius syndrome. | Klopocki E et al |
| 19569236 | 2009 | Cooperative interaction between protein inhibitor of activated signal transducer and activator of transcription-3 with epidermal growth factor receptor blockade in lung cancer. | Kluge A et al |
| 11893729 | 2002 | Androgen receptor-interacting protein 3 and other PIAS proteins cooperate with glucocorticoid receptor-interacting protein 1 in steroid receptor-dependent signaling. | Kotaja N et al |
| 16368885 | 2006 | Identifying a common molecular mechanism for inhibition of MITF and STAT3 by PIAS3. | Levy C et al |
| 11709556 | 2002 | A new role for the STAT3 inhibitor, PIAS3: a repressor of microphthalmia transcription factor. | Levy C et al |
| 14645519 | 2003 | Role played by microphthalmia transcription factor phosphorylation and its Zip domain in its transcriptional inhibition by PIAS3. | Levy C et al |
| 14691252 | 2004 | Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3). | Long J et al |
| 17486098 | 2007 | SUMOylation regulates kainate-receptor-mediated synaptic transmission. | Martin S et al |
| 10961991 | 2000 | Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. | Minty A et al |
| 15894620 | 2005 | The Arabidopsis SUMO E3 ligase SIZ1 controls phosphate deficiency responses. | Miura K et al |
| 12387893 | 2002 | PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1. | Nakagawa K et al |
| 12177000 | 2002 | PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription. | Nishida T et al |
| 17032498 | 2006 | Overexpression of PIAS3 suppresses cell growth and restores the drug sensitivity of human lung cancer cells in association with PI3-K/Akt inactivation. | Ogata Y et al |
| 19186166 | 2009 | Pias3-dependent SUMOylation directs rod photoreceptor development. | Onishi A et al |
| 18031232 | 2007 | PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription. | Palvimo JJ et al |
| 11997457 | 2002 | The intranuclear prolactin/cyclophilin B complex as a transcriptional inducer. | Rycyzyn MA et al |
| 19526197 | 2009 | PIAS proteins: pleiotropic interactors associated with SUMO. | Rytinki MM et al |
| 14685683 | 2003 | PIAS/SUMO: new partners in transcriptional regulation. | Schmidt D et al |
| 15961505 | 2005 | Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity. | Sentis S et al |
| 16056253 | 2005 | Regulation of gene-activation pathways by PIAS proteins in the immune system. | Shuai K et al |
| 15572665 | 2004 | Interplay between MITF, PIAS3, and STAT3 in mast cells and melanocytes. | Sonnenblick A et al |
| 19308990 | 2009 | The SUMO-E3 ligase PIAS3 targets pyruvate kinase M2. | Spoden GA et al |
| 11877418 | 2002 | Protein inhibitors of activated STAT resemble scaffold attachment factors and function as interacting nuclear receptor coregulators. | Tan JA et al |
| 10319586 | 1999 | Isolation and chromosomal assignment of a human gene encoding protein inhibitor of activated STAT3 (PIAS3). | Ueki N et al |
| 17728242 | 2007 | Ubiquitin-dependent proteolytic control of SUMO conjugates. | Uzunova K et al |
| 11877452 | 2002 | Increased K+ efflux and apoptosis induced by the potassium channel modulatory protein KChAP/PIAS3beta in prostate cancer cells. | Wible BA et al |
| 9565597 | 1998 | Cloning and expression of a novel K+ channel regulatory protein, KChAP. | Wible BA et al |
| 19201870 | 2009 | A specific epitope of protein inhibitor of activated STAT3 is responsible for the induction of apoptosis in rat transformed mast cells. | Yagil Z et al |
Other Information
Locus ID:
NCBI: 10401
MIM: 605987
HGNC: 16861
Ensembl: ENSG00000131788
Variants:
dbSNP: 10401
ClinVar: 10401
TCGA: ENSG00000131788
COSMIC: PIAS3
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000131788 | ENST00000369298 | E9PHH8 |
| ENSG00000131788 | ENST00000393045 | Q9Y6X2 |
| ENSG00000131788 | ENST00000393046 | E7ESB4 |
| ENSG00000131788 | ENST00000463514 | U3KQV1 |
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 34030529 | 2021 | LncRNA FOXD2-AS1 promotes cell proliferation and invasion of fibroblast-like synoviocytes by regulation of miR-331-3p/PIAS3 pathway in rheumatoid arthritis. | 10 |
| 34837964 | 2021 | PIAS3 suppresses damage in an Alzheimer's disease cell model by inducing the STAT3-associated STAT3/Nestin/Nrf2/HO-1 pathway. | 4 |
| 34030529 | 2021 | LncRNA FOXD2-AS1 promotes cell proliferation and invasion of fibroblast-like synoviocytes by regulation of miR-331-3p/PIAS3 pathway in rheumatoid arthritis. | 10 |
| 34837964 | 2021 | PIAS3 suppresses damage in an Alzheimer's disease cell model by inducing the STAT3-associated STAT3/Nestin/Nrf2/HO-1 pathway. | 4 |
| 32398867 | 2020 | Cancer exosome-derived miR-9 and miR-181a promote the development of early-stage MDSCs via interfering with SOCS3 and PIAS3 respectively in breast cancer. | 66 |
| 32398867 | 2020 | Cancer exosome-derived miR-9 and miR-181a promote the development of early-stage MDSCs via interfering with SOCS3 and PIAS3 respectively in breast cancer. | 66 |
| 30861611 | 2019 | PIAS genes as disease markers in bipolar disorder. | 3 |
| 30937952 | 2019 | miR-199a-5p promotes proliferation and metastasis and epithelial-mesenchymal transition through targeting PIAS3 in cervical carcinoma. | 15 |
| 31125786 | 2019 | SUMOylation of Csk Negatively Modulates its Tumor Suppressor Function. | 5 |
| 30861611 | 2019 | PIAS genes as disease markers in bipolar disorder. | 3 |
| 30937952 | 2019 | miR-199a-5p promotes proliferation and metastasis and epithelial-mesenchymal transition through targeting PIAS3 in cervical carcinoma. | 15 |
| 31125786 | 2019 | SUMOylation of Csk Negatively Modulates its Tumor Suppressor Function. | 5 |
| 29339537 | 2018 | STAT3/PIAS3 Levels Serve as "Early Signature" Genes in the Development of High-Grade Serous Carcinoma from the Fallopian Tube. | 12 |
| 29896300 | 2018 | PIAS3-mediated feedback loops promote chronic colitis-associated malignant transformation. | 17 |
| 29950561 | 2018 | Nuclear Smad6 promotes gliomagenesis by negatively regulating PIAS3-mediated STAT3 inhibition. | 35 |
Citation
Gilles Spoden ; Werner Zwerschke
PIAS3 (protein inhibitor of activated STAT, 3)
Atlas Genet Cytogenet Oncol Haematol. 2010-04-01
Online version: http://atlasgeneticsoncology.org/gene/41709/pias3-(protein-inhibitor-of-activated-stat-3)
